https://scholars.lib.ntu.edu.tw/handle/123456789/424787
標題: | Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury | 作者: | Shiao, Chih-Chung Kan, Wei-Chih Wang, Jian-Jhong YU-FENG LIN Chen, Likwang Chueh, Eric Huang, Ya-Ting Chiang, Wen-Po Tseng, Li-Jung CHIH-HSIEN WANG VIN-CENT WU |
關鍵字: | acute kidney injury; adverse cardiovascular events; atrial fibrillation; dialysis;Acute kidney injury; Adverse cardiovascular events; Atrial fibrillation; Dialysis | 公開日期: | 29-八月-2018 | 出版社: | MDPI | 卷: | 7 | 期: | 9 | 來源出版物: | Journal of clinical medicine | 摘要: | The influence of acute kidney injury (AKI) on subsequent incident atrial fibrillation (AF) has not yet been fully addressed. This retrospective nationwide cohort study was conducted using Taiwan's National Health Insurance Research Database from 1 January 2000 to 31 December 2010. A total of 41,463 patients without a previous AF, mitral valve disease, and hyperthyroidism who developed de novo dialysis-requiring AKI (AKI-D) during their index hospitalization were enrolled. After propensity score matching, "non-recovery group" (n = 2895), "AKI-recovery group" (n = 2895) and "non-AKI group" (control group, n = 5790) were categorized. Within a follow-up period of 6.52 ± 3.88 years (median, 6.87 years), we found that the adjusted risks for subsequent incident AF were increased in both AKI-recovery group (adjusted hazard ratio (aHR) = 1.30; 95% confidence intervals (CI), 1.07⁻1.58; p ≤ 0.01) and non-recovery group (aHR = 1.62; 95% CI, 1.36⁻1.94) compared to the non-AKI group. Furthermore, the development of AF carried elevated risks for major adverse cardiac events (aHR = 2.11; 95% CI, 1.83⁻2.43), ischemic stroke (aHR = 1.33; 95% CI, 1.19⁻1.49), and all stroke (aHR = 1.28; 95% CI, 1.15⁻1.43). (all p ≤ 0.001, except otherwise expressed) The authors concluded that AKI-D, even in those who withdrew from temporary dialysis, independently increases the subsequent risk of de novo AF. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/424787 | ISSN: | 2077-0383 | DOI: | 10.3390/jcm7090248 | SDG/關鍵字: | acetylsalicylic acid; antidiabetic agent; calcium channel blocking agent; clopidogrel; dipyridamole; diuretic agent; hydroxymethylglutaryl coenzyme A reductase inhibitor; nitrate; ticlopidine; acute kidney failure; adult; aged; Article; atrial fibrillation; brain ischemia; cerebrovascular accident; CHA2DS2-VASc score; Charlson Comorbidity Index; chronic kidney failure; chronic obstructive lung disease; cohort analysis; end stage renal disease; female; human; ICD-9-CM; major adverse cardiac event; major clinical study; male; mortality; propensity score; retrospective study; risk factor |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。